BenevolentAI refocuses business strategy, cuts workforce by 30%
Amsterdam-based biopharma AI leader BenevolentAI announced a strategic shift to concentrate on AI-driven drug discovery and proprietary pipeline revenue streams. The decision follows the discontinuation of its Knowledge Exploration Tools due to high commercialization costs and a lengthy ROI timeline….